Ifp Advisors, Inc Rocket Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$15.5 - $22.76 $77 - $113	5 Added 25.0%	25 $1,000
Q3 2022 Nov 08, 2022	BUY	$12.37 - $18.41 $247 - $368	20 New	20 $1,000
Q3 2021 Oct 06, 2021	SELL	$27.42 - $48.97 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$39.41 - $47.25 $591 - $708	-15 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$43.34 - $65.91 $43 - $65	-1 Reduced 6.25%	15 $0
Q4 2020 Jan 25, 2021	BUY	$23.3 - $59.57 $372 - $953	16 New	16 $0

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.